Effects of Dehydroepiandrosterone on In Vitro Fertilization Among Women Aging Over 35 Years and Normal Ovarian Reserve
Objective: The fertility potential of women declines with aging and the likelihood of infertility and stillbirth increase. Treatment protocols involving dehydroepiandrosterone (DHEA) provide pathways on improving fertility and live birth rate. This randomized clinical trial aimed to evaluate the effect of DHEA on In Vitro Fertilization (IVF) outcomes in women over 35 years and normal ovarian reserve.
Materials and methods: One hundred and six consecutive women with advanced reproductive age undergoing IVF due to infertility were enrolled in the study. Participants in the intervention group received 75 mg/day of DHEA orally 8 weeks before starting the cycle of ovulation induction. Participants in placebo group received placebo tablets during the same period. After 8 weeks, routine procedure of IVF was initiated then Clinical pregnancy, Miscarriage, Endometrial thickness and Duration of stimulation were evaluated for all the participants in both groups.
Results: There is no significant difference between groups in terms of age and BMI. Mean endometrial thickness was significantly lower in DHEA group (9.63 ± 0.70vs.8.05 ± 0.70; p < 0.001) while Duration of stimulation was higher (8.98 ± 1.29vs.10.59 ± 1.43; p < 0.001). There was no significant difference between pregnancy rate, and miscarriage rate of the groups.
Conclusion: According to the result of this study, DHEA supplementation may improve IVF outcomes in infertile women. Although additional larger and placebo-controlled studies using different DHEA protocols are required to support our present findings.
Broekmans F, Soules M, Fauser B. Ovarian aging: mechanisms and clinical consequences. Endocrine reviews. 2009;30(5):465-93.
Tartagni M, Cicinelli MV, Baldini D, Tartagni MV, Alrasheed H, DeSalvia MA, et al. Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old. Reproductive Biology and Endocrinology. 2015;13(1):18.
Cabry R, Merviel P, Hazout A, Belloc S, Dalleac A, Copin H, et al. Management of infertility in women over 40. Maturitas. 2014;78(1):17-21.
Arlt W. Dehydroepiandrosterone and ageing. Best Practice & Research Clinical Endocrinology & Metabolism. 2004;18(3):363-80.
Casson P, Lindsay M, Pisarska M, Carson S, Buster J. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Human Reproduction. 2000;15(10):2129-32.
Gleicher N, Weghofer A, Barad DH. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reproductive biomedicine online. 2010;21(3):360-5.
Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. Journal of assisted reproduction and genetics. 2007;24(12):629-34.
Sönmezer M, Özmen B, Cil A, Özkavukçu S, Taşçı T, Olmuş H, et al. Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders. Reproductive biomedicine online. 2009;19(4):508-13.
Saghaei M. Random allocation software for parallel group randomized trials. BMC medical research methodology. 2004;4(1):26.
Tartagni M, De pergola G, Pellegrino A, Baldini D, et al. Potential benefit of dehydroepiandrosterone supplementation for infertile but not poor responder patients in a IVF program. Minerva Ginecol. 2014;67(1):7-12.
Brad D, Gleicher N. Effect of dehidroepiandrosterone on oocyte and embryo grade and cell number in IVF. Hum Reprod 2006;21:2845-9.
Wiser A, Gonen O, Ghetler Y,et al. Addition of dehydroepiandrosterone for poor responder patients before and during IVF treatment improves the pregnancy rate: a randomizied prospective study. Hum Reprod 2010;25:2496-500.
Nark Wichean A, Maalouf W, Campbell BK, et al. Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta analysis. Reprod Biol Endocrinol2013;11:44.
Xu B, Li Z, Yue J, et al. Effect of dehydroepiandrosterone adminstration in patients with poor ovarian response according to the Bologna criteria. PLOS ONE 2014;9:e99858.
Glecher N, Weghofer A, Barod DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 2011;9:116.
Liu X, Wang W, Wang X, et al. Effect of dehydroepiandrosterone adminstration in chinese women over 37 years undergoing assisted reproductive techniques. European Jornal of Obstetrics & Gynecology and Reproductive Biology 2016;9:13.
|Issue||Vol 12, No 3 (September 2018)|
|Dehydroepiandrosterone IVF Infertility|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|